In a study of patients with breast cancer (Cheng et al. 2016), compared to patients with the GG genotype for COMT rs165599, patients with the GA and AA genotypes had a lower odds of developing self-reported cognitive decline. This evidence concerns the gene COMT and breast carcinoma.